A. Thompson

First name

A.

Last name

Thompson

Guthrie, B., Rogers, G., Livingstone, S., Morales, D. R., Donnan, P., Davis, S., et al. (2024). The implications of competing risks and direct treatment disutility in cardiovascular disease and osteoporotic fracture: risk prediction and cost effectiveness analysis. Health Soc Care Deliv Res, 12, 1-275. http://doi.org/10.3310/kltr7714

View

Livingstone, S. J., Guthrie, B., Donnan, P. T., Thompson, A., & Morales, D. R. (2022). Predictive performance of a competing risk cardiovascular prediction tool CRISK compared to QRISK3 in older people and those with comorbidity: population cohort study. Bmc Med, 20, 152. http://doi.org/10.1186/s12916-022-02349-6

View

Mackenzie, I. S., MacDonald, T. M., Thompson, A., Morant, S., & Wei, L. (2012). Spironolactone and risk of incident breast cancer in women older than 55 years: retrospective, matched cohort study. Bmj. http://doi.org/10.1136/bmj.e4447

View

Thompson, A., Ashcroft, D. M., Owens, L., van Staa, T. P., & Pirmohamed, M. (2017). Drug therapy for alcohol dependence in primary care in the UK: A Clinical Practice Research Datalink study. PLoS One. http://doi.org/10.1371/journal.pone.0173272

View

Thompson, A., Wright, A. K., Ashcroft, D. M., van Staa, T. P., & Pirmohamed, M. (2017). Epidemiology of alcohol dependence in UK primary care: Results from a large observational study using the Clinical Practice Research Datalink. PLoS One. http://doi.org/10.1371/journal.pone.0174818

View

Pate, A., Elliott, R. A., Gkountouras, G., Thompson, A., Emsley, R., & Van Staa, T. (2020). The impact of statin discontinuation and restarting rates on the optimal time to initiate statins and on the number of cardiovascular events prevented. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.5023

View